Meighan has the unique ability to simultaneously communicate the big-picture strategy and identify the tactical requirements to achieve results. Her keen analytical skills, collaborative problem-solving approach, and broad exposure across therapeutic areas enable an interdisciplinary approach to the key questions of commercial and medical affairs strategy.

Meighan joined The NemetzGroup in 2015. She has over 20 years of industry and consulting experience in new product planning, commercial assessment, business development, and global marketing strategy. She understands how to build teams and work cross-functionally from clinical to market access to lifecycle management with a US and global perspective.

As Director of Renal Global Strategy at Sanofi, Meighan oversaw the marketing and communications strategy, primary market research, business development support, and competitive intelligence. Meighan spent several years as the commercial lead for a portfolio of clinical and preclinical rare disease programs tasked with providing market and indication analyses to drive asset prioritization at Sanofi and Genzyme.

Meighan holds a BA from Hampshire College and an MLIS from the University of Illinois and has completed coursework in Epidemiology/Biostatistics at Tufts Medical School.